Gene · 11277
Papers2,317
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,317
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Significant Correlation Between White Matter Hyperintensity Volume and Rare NOTCH3 Variants in the General Japanese Population. | Geriatr Gerontol Int | 2026 | 41669960 | PubTator, text mining | PubMed |
| Ubiquitin control of cytosolic DNA sets immune responses to DNA damage. | Cancer Cell | 2026 | 41666875 | PubTator, text mining | PubMed |
| Ultrarare Variants in DNA Damage Repair and Mitochondrial Genes in Pediatric Acute-Onset Neuropsychiatric Syndrome and Acute Behavioral Regression in Neurodevelopmental Disorders. | Dev Neurosci | 2026 | 41662332 | PubTator, text mining | PubMed |
| SIRT4 regulates antiviral and autoimmune responses by promoting cGAS-mediated signaling pathways. | EMBO Rep | 2026 | 41634380 | PubTator, text mining | PubMed |
| Is it a secondary cause of vasculitis or a mimic? A case of retinal vasculopathy with cerebral leukoencephalopathy. | Mod Rheumatol Case Rep | 2026 | 41615015 | PubTator, text mining | PubMed |
| Nuclear mechanobiology in confined cell migration. | Nucleus | 2026 | 41610884 | PubTator, text mining | PubMed |
| Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK Biobank. | Nat Commun | 2026 | 41593088 | PubTator, text mining | PubMed |
| [Hypoxia and TREX1 exonuclease: an alliance that suppresses hepatitis B virus replication]. | Med Sci (Paris) | 2026 | 41575024 | PubTator, text mining | PubMed |
| Disordered DNA-binding motif forms a modulation site for inhibiting the cancer immunotherapy target TREX1. | Nucleic Acids Res | 2026 | 41533589 | PubTator, text mining | PubMed |
| Corrigendum to "TREX1 activators: A novel therapeutic strategy for rheumatoid arthritis management via cfDNA clearance" [Pharmacol. Res. 218 (2025) 107817]. | Pharmacol Res | 2026 | 41530001 | PubTator, text mining | PubMed |
| HIV-1 derived oligonucleotides induce a type I IFN/STING dependent immune suppression reversible by targeting IFNARI. | PLoS Pathog | 2026 | 41529066 | PubTator, text mining | PubMed |
| Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated immune response to DNA damage. | Cancer Cell | 2026 | 41512867 | PubTator, text mining | PubMed |
| An Overview of Drug-Resistant Epilepsies Based on Advances in Genetics: A Cohort Study. | Neurol India | 2026 | 41510857 | PubTator, text mining | PubMed |
| Research Progress of Radiotherapy Combined With Immunotherapy for Breast Cancer: Mechanism Exploration and Clinical Translation. | Clin Breast Cancer | 2026 | 41506017 | PubTator, text mining | PubMed |
| Acute liver failure as the first symptom of childhood systemic lupus erythematosus: a case report and review of the literature. | Med Mol Morphol | 2026 | 41364229 | PubTator, text mining | PubMed |
| A human-STING specific macrocyclic peptide suppresses cGAS-STING-induced inflammation. | Ann Rheum Dis | 2026 | 41290486 | PubTator, text mining | PubMed |
| TREX1, a predator for treating MSI-H tumors? | Mol Oncol | 2026 | 41288129 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Proliferative Senescence and Genomic Instability in Werner Syndrome and the WRN Gene Network. | Cytogenet Genome Res | 2026 | 40971347 | PubTator, text mining | PubMed |
| Towards precision medicine for systemic lupus erythematosus and neuropsychiatric manifestations. | Expert Rev Precis Med Drug Dev | 2025 | 42281945 | PubTator, text mining | PubMed |
| Exploring targeted therapy in retinal vasculopathy with cerebral leukoencephalopathy: a case report and review of literature. | Front Immunol | 2025 | 41613112 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11277/papers?page=3